Benzimidazolium Salts Bearing Nitrile Moieties: Synthesis, Enzyme Inhibition Profiling, and Molecular Docking Analysis for Carbonic Anhydrase and Acetylcholinesterase
Chemistry & Biodiversity · 2023-12 · 20 (12)
DOI: 10.1002/cbdv.202301362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 20.11.2023. Verfasst von Erkan Öner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Adıyaman University, 02040-, Adıyaman, Türkiye. Hauptthemen laut MEDLINE: Carbonic Anhydrases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Research Fund of Mersin University in Turkey.
Abstract (Originalsprache)
This report presents the synthesis and characterization of a range of benzimidazolium salts featuring 3‐cyanopropyl groups on the 1 st nitrogen atom and varied alkyl groups on the 3 rd nitrogen atom within the benzimidazole structure. Benzimidazolium salts were synthesized by N‐alkylation of 1‐alkyl benzimidazole with 3‐cyanopropyl‐bromide. The new salts were characterized by 1 H and 13 C‐NMR, FT‐IR spectroscopic and elemental analysis techniques. In this study, the enzyme inhibition abilities of seven nitrile substituted benzimidazolium salts were investigated against acetylcholinesterase (AChE) and carbonic anhydrase isoenzymes I and II (hCA I and hCA II). They showed a highly potent inhibition effect on AChE, hCA I and hCA II (K i values are in the range of 26.71–119.09 nM for AChE, 19.77 to 133.68 nM for hCA I and 13.09 to 266.38 nM for hCA II). Reflecting the binding mode of the synthesized cyanopropyl series, the importance of the 2,3,5,6‐tetramethylbenzyl, 3‐methylbenzyl and 3‐benzyl groups for optimal interactions with target proteins, evaluated by molecular docking studies. At the same time, the docking findings support the inhibition constants (K i ) values of the related compounds in this study. Potential compounds were also evaluated by their pharmacokinetic properties were predicted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Adıyaman University, 02040-, Adıyaman, Türkiye.
- Department of Chemistry, Faculty of Arts and Science, Inönü University, 44280-, Malatya, Türkiye.
- Organic and Organometallic Chemistry Research Laboratory, Department of Chemistry, Faculty of Arts and Science, Inönü University, 44280-, Malatya, Türkiye.
- Nihat Delibalta Göle Vocational High School, Ardahan University, 75700, -Ardahan, Türkiye.
- Department of Chemistry, Faculty of Arts and Sciences, Gaziantep University, 27310-, Gaziantep, Türkiye.
- Department of Bioinformatics and Computational Biology, Institute of Health Sciences, Gaziantep University, 27310-, Gaziantep, Türkiye.
ORCID-Profile: Erkan Öner, Yeliz Demir, Tugba Taskin-Tok, Aydın Aktaş, İlhami Gülçin, Serap Yalın
Förderung
- Research Fund of Mersin University in Turkey
Zitieren
APA
Öner, E., Gök, Y., Demir, Y., Taskin-Tok, T., Aktaş, A., Gülçin, İ., & Yalın, S. (2023). Benzimidazolium Salts Bearing Nitrile Moieties: Synthesis, Enzyme Inhibition Profiling, and Molecular Docking Analysis for Carbonic Anhydrase and Acetylcholinesterase. Chemistry & Biodiversity, 20(12). https://doi.org/10.1002/cbdv.202301362
Vancouver
Öner E, Gök Y, Demir Y, Taskin-Tok T, Aktaş A, Gülçin İ, et al. Benzimidazolium Salts Bearing Nitrile Moieties: Synthesis, Enzyme Inhibition Profiling, and Molecular Docking Analysis for Carbonic Anhydrase and Acetylcholinesterase. Chemistry & Biodiversity. 2023;20(12). doi:10.1002/cbdv.202301362
BibTeX
@article{ner2023,
author = {Öner, Erkan and Gök, Yetkin and Demir, Yeliz and Taskin-Tok, Tugba and Aktaş, Aydın and Gülçin, İlhami and Yalın, Serap},
title = {Benzimidazolium Salts Bearing Nitrile Moieties: Synthesis, Enzyme Inhibition Profiling, and Molecular Docking Analysis for Carbonic Anhydrase and Acetylcholinesterase},
journal = {Chemistry & Biodiversity},
year = {2023},
volume = {20},
number = {12},
doi = {10.1002/cbdv.202301362}
}
EUVIMED